R. Tanaka

发表

A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity

Naoki Yamamoto, Yuetsu Tanaka, Hiroshi Takaku, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Unique Monoclonal Antibody Recognizing the Third Extracellular Loop of CXCR4 Induces Lymphocyte Agglutination and Enhances Human Immunodeficiency Virus Type 1-Mediated Syncytium Formation and Productive Infection

E. Baba, Yuetsu Tanaka, Tohru Kimura, 2001, Journal of Virology.

The Novel CXCR 4 Antagonist KRH-3955 Is an Orally Bioavailable and Extremely Potent Inhibitor of Human Immunodeficiency Virus Type 1 Infection : Comparative Studies with AMD 3100

Yuetsu Tanaka, N. Yamamoto, Wei Huang, 2009 .

The Novel CXCR4 Antagonist KRH-3955 Is an Orally Bioavailable and Extremely Potent Inhibitor of Human Immunodeficiency Virus Type 1 Infection: Comparative Studies with AMD3100

Yuetsu Tanaka, N. Yamamoto, Wei Huang, 2009, Antimicrobial Agents and Chemotherapy.

Conservation of a Neutralization Epitope of Human T-cell Leukemia Virus Type 1 (HTLV-1) among Currently Endemic Clinical Isolates in Okinawa, Japan

Yuetsu Tanaka, T. Fukushima, R. Tanaka, 2020, Pathogens.

Rapid induction of OX40 ligand on primary T cells activated under DNA-damaging conditions.

Yuetsu Tanaka, G. Matsuzaki, K. Kondo, 2008, Human immunology.

Functional CD4 T Cells after Intercellular Molecular Transfer of OX40 Ligand1

E. Baba, K. Sugamura, Yuetsu Tanaka, 2001, The Journal of Immunology.

Heat Shock Enhances the Expression of the Human T Cell Leukemia Virus Type-I (HTLV-I) Trans-Activator (Tax) Antigen in Human HTLV-I Infected Primary and Cultured T Cells

Yuetsu Tanaka, T. Miyagi, H. Fujii, 2016, Viruses.

Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain

J. Kira, Y. Ueyama, N. Yamamoto, 1997, Journal of virology.

Generation of Mature Dendritic Cells with Unique Phenotype and Function by In Vitro Short-Term Culture of Human Monocytes in the Presence of Interleukin-4 and Interferon-β

Yuetsu Tanaka, K. Kondo, R. Tanaka, 2008, Experimental biology and medicine.

Cross-Linking Cell Surface Chemokine Receptors Leads to Isolation, Activation, and Differentiation of Monocytes into Potent Dendritic Cells

Yuetsu Tanaka, N. Yamamoto, R. Tanaka, 2006, Experimental biology and medicine.

Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses

Yuetsu Tanaka, T. Adachi, M. Saito, 2011, Retrovirology.

Impairment of in vitro generation of monocyte-derived human dendritic cells by inactivated human immunodeficiency virus-1: Involvement of type I interferon produced from plasmacytoid dendritc cells.

Yuetsu Tanaka, T. Adachi, M. Saito, 2010, Human immunology.

Induction of Protective Immune Responses against R5 Human Immunodeficiency Virus Type 1 (HIV-1) Infection in hu-PBL-SCID Mice by Intrasplenic Immunization with HIV-1-Pulsed Dendritic Cells: Possible Involvement of a Novel Factor of Human CD4+ T-Cell Origin

Mamoru Ito, Yuetsu Tanaka, N. Yamamoto, 2003, Journal of Virology.

High levels of viremia in hu-PBL-NOD-scid mice with HIV-1 infection.

Y. Ueyama, N. Yamamoto, Y. Tanaka, 1997, Leukemia.

Productive and lytic infection of human CD4+ type 1 helper T cells with macrophage-tropic human immunodeficiency virus type 1

N. Yamamoto, Y. Tanaka, Y. Kumazawa, 1997, Journal of virology.

Effects of Surfactant Protein‐A on the Interaction of Pneumocystis murina with its Host at Different Stages of the Infection in Mice

L. Levin, P. Walzer, J. Koch, 2009, The Journal of eukaryotic microbiology.

Prevalence of plasma autoantibody against cancer testis antigen NY-ESO-1 in HTLV-1 infected individuals with different clinical status

Yuetsu Tanaka, H. Takashima, T. Matsuzaki, 2017, Virology Journal.

Resolution of Pneumocystis murina infection following withdrawal of corticosteroid induced immunosuppression.

P. Walzer, J. Koch, R. Tanaka, 2006, Microbial pathogenesis.

Surfactant protein A limits Pneumocystis murina infection in immunosuppressed C3H/HeN mice and modulates host response during infection.

P. Walzer, J. Koch, R. Tanaka, 2005, Microbes and infection.

Association of high levels of plasma OX40 with acute adult T-cell leukemia

Yuetsu Tanaka, T. Miyagi, M. Saito, 2019, International Journal of Hematology.

Natural OX40L expressed on human T cell leukemia virus type-I-immortalized T cell lines interferes with infection of activated peripheral blood mononuclear cells by CCR5-utilizing human immunodeficiency virus

Yuetsu Tanaka, R. Tanaka, A. Ansari, 2013, Virology Journal.

Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis

Yuetsu Tanaka, S. Izumo, H. Takashima, 2013, Retrovirology.

Suppression of CCR5-tropic HIV type 1 infection by OX40 stimulation via enhanced production of β-chemokines.

Yuetsu Tanaka, M. Saito, R. Tanaka, 2010, AIDS research and human retroviruses.

A novel and simple method for generation of human dendritic cells from unfractionated peripheral blood mononuclear cells within 2 days: its application for induction of HIV-1-reactive CD4+ T cells in the hu-PBL SCID mice

Yuetsu Tanaka, M. Saito, R. Tanaka, 2013, Front. Microbiol..

A recombinant vesicular stomatitis virus encoding HIV-1 receptors and human OX40 ligand efficiently eliminates HIV-1-infected CD4-positive T cells expressing OX40.

K. Yamaguchi, Yuetsu Tanaka, I. Hamaguchi, 2011, Human immunology.

Enhancement of OX40-induced apoptosis by TNF coactivation in OX40-expressing T cell lines in vitro leading to decreased targets for HIV type 1 production.

Yuetsu Tanaka, N. Yamamoto, R. Tanaka, 2008, AIDS research and human retroviruses.

Serologic responses to epitopes of the major surface glycoprotein of Pneumocystis jiroveci differ in human immunodeficiency virus-infected and uninfected persons.

C. Fichtenbaum, P. Walzer, R. Tanaka, 2002, The Journal of infectious diseases.

A novel mother-to-child human T-cell leukaemia virus type 1 (HTLV-1) transmission model for investigating the role of maternal anti-HTLV-1 antibodies using orally infected mother rats.

A. Hasegawa, T. Masuda, Yuetsu Tanaka, 2017, The Journal of general virology.

Identification of a novel neutralization epitope on envelope GP46 antigen of human t‐cell‐leukemia virus‐type‐II (HTLV‐II)

Yuetsu Tanaka, H. Hoshino, R. Tanaka, 1994, International journal of cancer.

Absolute quantification of HTLV-1 basic leucine zipper factor (HBZ) protein and its plasma antibody in HTLV-1 infected individuals with different clinical status

Yuetsu Tanaka, H. Takashima, T. Matsuzaki, 2016, Retrovirology.

A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I

Yuetsu Tanaka, T. Miyagi, H. Fujii, 2016, Viruses.

Elimination of human T cell leukemia virus type-1-infected cells by neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies against human t cell leukemia virus type-1 envelope gp46.

A. Hasegawa, Yuetsu Tanaka, M. Kannagi, 2014, AIDS research and human retroviruses.

Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization

E. Baba, N. Yamamoto, Y. Tanaka, 1994, Journal of virology.

Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor

Yuetsu Tanaka, S. Matsuoka, I. Hamaguchi, 2017, Journal of Virology.

Human T-cell leukemia virus type-I Tax induces the expression of CD83 on T cells

Yuetsu Tanaka, Masataka Nakamura, H. Fujii, 2015, Retrovirology.

Mutational analysis of human immunodeficiency virus type 1 (HIV-1) accessory genes: requirement of a site in the nef gene for HIV-1 replication in activated CD4+ T cells in vitro and in vivo

J. Kira, N. Yamamoto, Y. Tanaka, 1997, Journal of virology.

Identification of HIV-1 Epitopes that Induce the Synthesis of a R5 HIV-1 Suppression Factor by Human CD4+ T Cells Isolated from HIV-1 Immunized Hu-PBL SCID Mice

Yuetsu Tanaka, N. Yamamoto, A. Yoshida, 2005, Clinical & developmental immunology.

Efficient resolution of Pneumocystis murina infection in surfactant protein A-deficient mice following withdrawal of corticosteroid-induced immunosuppression.

P. Walzer, J. Koch, R. Tanaka, 2006, Journal of medical microbiology.

Absolute quantification of HTLV-1 basic leucine zipper factor (HBZ) protein and its plasma antibody in HTLV-1 infected individuals with different clinical status

Yuetsu Tanaka, H. Takashima, T. Matsuzaki, 2016, Retrovirology.

Human T-cell leukemia virus type-I Tax induces the expression of CD 83 on T cells

Yuetsu Tanaka, Masataka Nakamura, H. Fujii, 2022 .

Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.

Yuetsu Tanaka, N. Yamamoto, K. Kondo, 2007, Human immunology.

Interleukin-4-transgenic hu-PBL-SCID mice: a model for the screening of antiviral drugs and immunotherapeutic agents against X4 HIV-1 viruses.

Mamoru Ito, W. Sugiura, Yuetsu Tanaka, 2008, The Journal of infectious diseases.

The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID/γcnull (NOG) mice

Yuetsu Tanaka, H. Takashima, H. Fujii, 2014, Retrovirology.

Noninvasive Method for Monitoring Pneumocystis carinii Pneumonia

M. Cushion, M. Collins, R. Tanaka, 2003, Emerging infectious diseases.

Elevation of the Plasma Levels of TNF Receptor 2 in Association with Those of CD25, OX40, and IL-10 and HTLV-1 Proviral Load in Acute Adult T-Cell Leukemia

K. Karube, Yuetsu Tanaka, H. Masuzaki, 2022, Viruses.

Prevalence of plasma autoantibody against cancer testis antigen NY-ESO-1 in HTLV-1 infected individuals with different clinical status

Yuetsu Tanaka, H. Takashima, T. Matsuzaki, 2017, Virology Journal.

A protective role of HTLV-1 gp46-specific neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies in progression to adult T-cell leukemia (ATL)

Yuetsu Tanaka, H. Masuzaki, T. Fukushima, 2022, Frontiers in Immunology.

Yuetsu Tanaka, R. Tanaka, A. Ansari, 2013, Virology Journal.

Neutralizing antibodies against human T cell leukemia virus type-I (HTLV-1) eradicate HTLV-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection

Yuetsu Tanaka, R. Tanaka, Akira Kodama, 2014, Retrovirology.